Targeting poor prognosis leukemia with CD25-targeted chemokine receptor expressing CAR T cell therapy

Ari Itoh-Nakadai

9:59 AM - 10:17 AM

[1S12m-04] Targeting poor prognosis leukemia with CD25-targeted chemokine receptor expressing CAR T cell therapy

^○Ari Itoh-Nakadai^1,2, Fumihiko Ishikawa¹ (1.Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences, 2.Department of Hygiene and Public Health, Graduate School of Medicine, Nippon Medical School)

キーテクノロジー：T 細胞エンジニアリング

CAR-T、PDX、AML、ヒト化マウス

ari.itoh@riken.jp

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 94th Annual Meeting of JBS

[1S12m-04] Targeting poor prognosis leukemia with CD25-targeted chemokine receptor expressing CAR T cell therapy

Password